Cargando…

Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer

SIMPLE SUMMARY: Total thyroidectomy used to be recommended for all thyroid cancers. We now know that some thyroid cancers have a relatively low risk of recurrence. Today, for some of these cancers, depending on the type of tumor, its’ size and other tumor characteristics, a thyroid lobectomy (or hem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartl, Dana M., Guerlain, Joanne, Breuskin, Ingrid, Hadoux, Julien, Baudin, Eric, Al Ghuzlan, Abir, Terroir-Cassou-Mounat, Marie, Lamartina, Livia, Leboulleux, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694652/ https://www.ncbi.nlm.nih.gov/pubmed/33171949 http://dx.doi.org/10.3390/cancers12113282

Ejemplares similares

Differentiated Thyroid Cancer in Children and Adolescents: Long Term Outcome and Risk Factors for Persistent Disease
por: Sapuppo, Giulia, et al.
Publicado: (2021)

Pathological Analysis of Encased Resected Recurrent Nerves in Locally Invasive Thyroid Cancer
por: Dahan, Alexandre, et al.
Publicado: (2022)

Strategies for Radioiodine Treatment: What’s New
por: Sparano, Clotilde, et al.
Publicado: (2022)

Anaplastic Thyroid Carcinoma: An Update
por: Jannin, Arnaud, et al.
Publicado: (2022)

Screening for Prognostic Biomarkers in Metastatic Adrenocortical Carcinoma by Tissue Micro Arrays Analysis Identifies P53 as an Independent Prognostic Marker of Overall Survival
por: Hescot, Segolene, et al.
Publicado: (2022)

Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
por: Jannin, Arnaud, et al.
Publicado: (2022)

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer
por: Bardet, Stéphane, et al.
Publicado: (2022)

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)
por: Leboulleux, Sophie, et al.
Publicado: (2021)

Kinase inhibitors for advanced medullary thyroid carcinoma
por: Schlumberger, Martin, et al.
Publicado: (2012)

Endoscopic thyroid lobectomy vs Conventional open thyroid lobectomy
por: Imran, Mariam, et al.
Publicado: (2020)

RadioLigand Therapy with [(177)Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France
por: Terroir, Marie, et al.
Publicado: (2023)

RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
por: Deandreis, Désirée, et al.
Publicado: (2021)

Esophageal fistula complicating thyroid lobectomy
por: Ward, Nicholas D., et al.
Publicado: (2015)

Recent advances in managing differentiated thyroid cancer
por: Lamartina, Livia, et al.
Publicado: (2018)

Evaluation of voice function after BABA robotic thyroid lobectomy: A comparative analysis with endoscopic thyroid lobectomy
por: Liu, Peigen, et al.
Publicado: (2022)

Radiation exposure and thyroid cancer: a review
por: Iglesias, Maria Laura, et al.
Publicado: (2017)

Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2022)

Treatment of distant metastases from follicular cell-derived thyroid cancer
por: Schlumberger, Martin, et al.
Publicado: (2015)

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging
por: Pellegriti, G, et al.
Publicado: (2003)

International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma
por: Xu, Bin, et al.
Publicado: (2022)

Thyroid lobectomy is sufficient for differentiated thyroid cancer with upgraded risk after surgery
por: Choi, Soon Min, et al.
Publicado: (2022)

Thyroid Incidentalomas: Epidemiology, Risk Stratification with Ultrasound and Workup
por: Russ, Gilles, et al.
Publicado: (2014)

Efficacy and safety of radiofrequency ablation for benign thyroid nodules in patients with previous thyroid lobectomy
por: Yan, Lin, et al.
Publicado: (2021)

Intraoperative Autofluorescence Imaging for Parathyroid Gland Identification during Total Laryngectomy with Thyroidectomy †
por: Obongo Anga, Raïs, et al.
Publicado: (2023)

THE HISTOLOGICAL CHANGES IN THE THYROID GLAND OF THE RABBIT FOLLOWING LOBECTOMY
por: Crawford, J. Hamilton, et al.
Publicado: (1925)

Interobserver agreement of various thyroid imaging reporting and data systems
por: Grani, Giorgio, et al.
Publicado: (2017)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Prediction of Thyroid Hormone Replacement Following Thyroid Lobectomy: A Long-term Retrospective Study
por: Meyer, Charles, et al.
Publicado: (2021)

ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

Localization and characterization of thyroid microcalcifications: A histopathological study
por: Guerlain, Joanne, et al.
Publicado: (2019)

A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol
por: Lee, Eun Kyung, et al.
Publicado: (2021)

Loco-Regional Therapies in Oligometastatic Adrenocortical Carcinoma
por: Roux, Charles, et al.
Publicado: (2022)

Radioactive Iodine Following Total Thyroidectomy Is Comparable to Lobectomy in Low/Intermediate-Risk Differentiated Thyroid Carcinoma: A Meta-Analysis
por: Altedlawi Albalawi, Ibrahim A, et al.
Publicado: (2020)

Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial
por: Hartl, Dana, et al.
Publicado: (2023)

Comparison of the Incidence of Postoperative Hypothyroidism in Patients Undergoing Conventional Thyroid Lobectomy and Pyramid- and Isthmus-Preserving Lobectomy
por: Cho, Min Jeong, et al.
Publicado: (2021)

Prevalence of hypothyroidism among patients with isthmus-preserved thyroid lobectomy
por: Salih, Abdulwahid M.
Publicado: (2018)

SUN-622 Graves Disease Triggered by Lobectomy for Thyroid Cancer
por: Woods, Allison, et al.
Publicado: (2019)

Subacute lymphocytic thyroiditis after lobectomy in a patient with papillary thyroid carcinoma: a case report
por: Choi, Young Sik, et al.
Publicado: (2013)

Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
por: Kim, Soo Young, et al.
Publicado: (2020)

Is thyroid nodule location associated with malignancy risk?
por: Ramundo, Valeria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2dv84q718piri9a4h3o0euogv4